Patents by Inventor Soren E. Bjorn

Soren E. Bjorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest
    Publication number: 20100028939
    Abstract: This invention relates to novel compounds, methods for selective chemical conjugation of protractor molecules and the use thereof for diagnostic and/or therapeutic purposes.
    Type: Application
    Filed: April 1, 2008
    Publication date: February 4, 2010
    Applicant: Novo Nordisk Healthcare A/G
    Inventors: Carsten Behrens, Patrick William Garibay, Magali Zundel, Niels Kristian Klausen, Soren E. Bjorn
  • TF binding compound
    Publication number: 20040110929
    Abstract: The present invention relates to novel compounds that bind to and inhibit the activity of tissue factor (TF) and mediate a cytolytic immune response.
    Type: Application
    Filed: July 11, 2003
    Publication date: June 10, 2004
    Inventors: Soren E. Bjorn, Else Marie Nicolaisen, Thomas Dock Steenstrup
  • TF antagonist
    Publication number: 20040072755
    Abstract: This invention relates to novel compounds which bind to tissue factor and mediate a cytotoxic response.
    Type: Application
    Filed: July 11, 2003
    Publication date: April 15, 2004
    Inventors: Henning Ralf Stennicke, Soren E. Bjorn, Lars Christian Petersen
  • TFF peptides
    Publication number: 20020151472
    Abstract: A trefoil factor peptide.
    Type: Application
    Filed: December 7, 2001
    Publication date: October 17, 2002
    Inventors: Lars Thim, Soren E. Bjorn, Asser Sloth Andersen, Steen Seier Poulsen